Immunohistochemical staining of parafibromin in parathyroid tumors and other HPT-JT-associated tumors is an indirect method to recognize HPT-JT syndrome patients. This evidence concerns the gene CDC73 and Hyperparathyroidism-jaw tumor syndrome.